Implications of Nagoya protocol implementation for the pharmaceutical and cosmetic industries

被引：0
|
作者：
David, B. [1 ]
机构：
[1] Pierre Fabre Res Inst, Toulouse, France
来源：
PLANTA MEDICA | 2012年 / 78卷 / 11期
关键词：
D O I：
暂无
中图分类号：
Q94 [植物学];
学科分类号：
071001 ;
摘要：
引用
收藏
页码：1058 / 1058
页数：1
相关论文
共 50 条
  • [31] The Nagoya–Kuala Lumpur Supplementary Protocol on Liability and Redress to the Cartagena Protocol on Biosafety: An analysis and implementation challenges
    Gurdial Singh Nijar
    International Environmental Agreements: Politics, Law and Economics, 2013, 13 : 271 - 290
  • [32] Raw biowaste conversion to high-value compounds for food, cosmetic and pharmaceutical industries
    Krbeckova, Veronika
    Placha, Daniela
    ENVIRONMENTAL RESEARCH, 2024, 263
  • [33] Phenylpropanoids and its derivatives: biological activities and its role in food, pharmaceutical and cosmetic industries
    Neelam
    Khatkar, Anurag
    Sharma, Krishna Kant
    CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 2020, 60 (16) : 2655 - 2675
  • [34] Implementation of the protocol on pharmaceutical care in diabetes in Portugal
    Fernandez-Llimos, Fernando
    Silva, Teresa A.
    PHARMACY WORLD & SCIENCE, 2009, 31 (04): : 495 - 495
  • [35] Implementation of process optimization to maximize line productivity in pharmaceutical industries
    El Maaboud, Mahmoud R. Abd
    Kassem, Sally S.
    Elatriby, Sherif A.
    Fahim, Irene S.
    SN APPLIED SCIENCES, 2023, 5 (12):
  • [36] Implementation of process optimization to maximize line productivity in pharmaceutical industries
    Mahmoud R. Abd El Maaboud
    Sally S. Kassem
    Sherif A. Elatriby
    Irene S. Fahim
    SN Applied Sciences, 2023, 5
  • [37] Access to genetic resources and benefit sharing: Implications of Nagoya Protocol on providers and users
    Kariyawasam, Kanchana
    Tsai, Matthew
    JOURNAL OF WORLD INTELLECTUAL PROPERTY, 2018, 21 (5-6): : 289 - 305
  • [38] The Recent EC Draft Concerning the Nagoya Protocol: Challenges for the Industry with a Special Regard to the Pharmaceutical Sector
    Schacht, Hubertus
    BIOTECHNOLOGY LAW REPORT, 2014, 33 (03) : 115 - 119
  • [39] Chapter 2. The International Human Rights Law Implications of the Nagoya Protocol
    Savaresi, Annalisa
    2010 NAGOYA PROTOCOL ON ACCESS AND BENEFIT-SHARING IN PERSPECTIVE: IMPLICATIONS FOR INTERNATIONAL LAW AND IMPLEMENTATION CHALLENGES, 2013, 1 : 53 - 81
  • [40] The Nagoya Protocol: Fragmentation or Consolidation?
    Richerzhagen, Carmen
    RESOURCES-BASEL, 2014, 3 (01): : 135 - 151
12345